바이오인

 

1. Foreword.......... i
2. Acknowledgement.......... ii
3. Abbreviations.......... iii
4. Introduction.......... 1
5. Aims and scope ..........1
6. General Principles ..........1
7. Mechanism for review and monitoring ..........2
8. Classification of human stem cells.......... 3
9. Categorization of research on stem cells.......... 3
  9.1 Permissible areas of research ..........3
  9.2 Restricted areas of research.......... 4
  9.3 Prohibited areas of research.......... 5
10. Clinical use of umbilical cord blood stem cells ..........6
11. Research using fetal stem cells/placenta.......... 7
12. Approval for derivation of new hES cell lines.......... 7
13. Responsibility of investigator and institution ..........8
14. Procurement of gametes, blastocysts or ..........8
      somatic cells for generation of hES cell lines
15. Banking and distribution of hES cell lines.......... 10
16. Use of stem cells for therapeutic purpose.......... 11
17. International collaboration.......... 12
18. Commercialization and patent issues.......... 12
19. References ..........13
20. Expert Group and Drafting Committee Members.......... 14
21. Annexure I Monitoring mechanism.......... 15
22. Annexure II Safeguards to use hES cells.......... 18
23. Annexure III Clinical trial protocol for stem cells therapy.......... 19
24. Glossary.......... 22
25. Standards for collection processing and storage of cells.......... 25
      for clinical use